Search research articles
Contact Us
Filters
Showing results (81-90 of 242) with videos related to
Page
of 25
Sort By:
Neuro-Oncology
|
May 9, 2017
Preclinical drug screen reveals topotecan, actinomycin D, and volasertib as potential new therapeutic candidates for ETMR brain tumor patients
Christin Schmidt, Nil A Schubert, Sebastian Brabetz, et al.
JCO Precision Oncology
|
May 14, 2026
Switching Tracks: Activity of Entrectinib After Progression While on Larotrectinib in Neurotrophin Receptor Tyrosine Kinase-Fused Pediatric High-Grade CNS Tumors
Emily C Hardin, Sebastian Stark, Claudia Zinke, et al.
Clinical Pharmacology and Therapeutics
|
May 29, 2021
A Study of Regulatory Challenges of Pediatric Oncology Phase I/II Trial Submissions and Guidance on Protocol Development
Lydia Beck, Ruth Witt, Martina Nesper-Brock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 29, 2023
Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory <i>BRAF</i> V600-Mutant Pediatric High-Grade Glioma
Darren R Hargrave, Keita Terashima, Junichi Hara, et al.
The Biochemical Journal
|
April 4, 2008
Identification of novel small-molecule histone deacetylase inhibitors by medium-throughput screening using a fluorigenic assay
Dennis Wegener, Christian Hildmann, Daniel Riester, et al.
Cancers
|
July 24, 2021
Neurocognitive Outcomes in Pediatric Patients Following Brain Irradiation
Katharina Weusthof, Peggy Lüttich, Sebastian Regnery, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2010
Molecular staging of intracranial ependymoma in children and adults
Andrey Korshunov, Hendrik Witt, Thomas Hielscher, et al.
Molecular Cancer Therapeutics
|
June 10, 2021
International Consensus on Minimum Preclinical Testing Requirements for the Development of Innovative Therapies For Children and Adolescents with Cancer
Gilles Vassal, Peter J Houghton, Stefan M Pfister, et al.
Cell Cycle (Georgetown, Tex.)
|
April 11, 2018
Reactivation of endogenous retroviral elements via treatment with DNMT- and HDAC-inhibitors
Michael Daskalakis, David Brocks, Yi-Hua Sheng, et al.
Pharmaceutical Medicine
|
May 4, 2026
Paediatric Phase I/II Clinical Trial Assessments Under the New EU Clinical Trial Regulation: A Descriptive Analysis
Laura Fankhauser, Franca Ligas, Giovanni Lesa, et al.
Page
of 25
Search research articles
Search
Showing results (81-90 of 242) with videos related to
Sort By:
Page
of 25
Neuro-Oncology
|
May 9, 2017
Preclinical drug screen reveals topotecan, actinomycin D, and volasertib as potential new therapeutic candidates for ETMR brain tumor patients
Christin Schmidt, Nil A Schubert, Sebastian Brabetz, et al.
JCO Precision Oncology
|
May 14, 2026
Switching Tracks: Activity of Entrectinib After Progression While on Larotrectinib in Neurotrophin Receptor Tyrosine Kinase-Fused Pediatric High-Grade CNS Tumors
Emily C Hardin, Sebastian Stark, Claudia Zinke, et al.
Clinical Pharmacology and Therapeutics
|
May 29, 2021
A Study of Regulatory Challenges of Pediatric Oncology Phase I/II Trial Submissions and Guidance on Protocol Development
Lydia Beck, Ruth Witt, Martina Nesper-Brock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 29, 2023
Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory <i>BRAF</i> V600-Mutant Pediatric High-Grade Glioma
Darren R Hargrave, Keita Terashima, Junichi Hara, et al.
The Biochemical Journal
|
April 4, 2008
Identification of novel small-molecule histone deacetylase inhibitors by medium-throughput screening using a fluorigenic assay
Dennis Wegener, Christian Hildmann, Daniel Riester, et al.
Cancers
|
July 24, 2021
Neurocognitive Outcomes in Pediatric Patients Following Brain Irradiation
Katharina Weusthof, Peggy Lüttich, Sebastian Regnery, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2010
Molecular staging of intracranial ependymoma in children and adults
Andrey Korshunov, Hendrik Witt, Thomas Hielscher, et al.
Molecular Cancer Therapeutics
|
June 10, 2021
International Consensus on Minimum Preclinical Testing Requirements for the Development of Innovative Therapies For Children and Adolescents with Cancer
Gilles Vassal, Peter J Houghton, Stefan M Pfister, et al.
Cell Cycle (Georgetown, Tex.)
|
April 11, 2018
Reactivation of endogenous retroviral elements via treatment with DNMT- and HDAC-inhibitors
Michael Daskalakis, David Brocks, Yi-Hua Sheng, et al.
Pharmaceutical Medicine
|
May 4, 2026
Paediatric Phase I/II Clinical Trial Assessments Under the New EU Clinical Trial Regulation: A Descriptive Analysis
Laura Fankhauser, Franca Ligas, Giovanni Lesa, et al.
Page
of 25